CLINICAL_TRIALS ClinicalTrials.gov record update

T-cell Infusion Targeting BCMA and CD19 for Refractory/Relapsed Systemic Lupus Erythematosus (SLE) Patients With or Without Organs Involvement

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06350110
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:07.912129+00:00
Published At: 2024-10-15T00:00:00+00:00
Record Updated At: 2024-10-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Systemic Lupus Erythematosus", "Lupus Nephritis", "Autoimmune Diseases", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Granulomatous Polyangiitis", "Microscopic Polyangiitis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Sjogren\u0027s Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-10-15"
protocolSection.identificationModule.nctId: "NCT06350110"
protocolSection.identificationModule.officialTitle: "T-cell Infusion Targeting BCMA and CD19 for Refractory/Relapsed Systemic Lupus Erythematosus (SLE) Patients With or Without Organs Involvement"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.